KEY FINDINGS
The global neurorehabilitation device market is set to record growth, projecting a CAGR of 15.16% during the forecast period, 2019-2028. The increasing geriatric population, rising neurological diseases, technological advancements, and the increasing neurorehabilitation device wearables and robotics, are the factors impacting the growth of the market in a positive manner.
MARKET INSIGHTS
The growing prevalence of neurological disorders is leading to increased adoption of neurorehabilitation devices, which is a major boost to the growth of the market. At the same time, the wearable and robotics for neurorehabilitation are witnessing steady growth. These aid the patients, professionals, and researchers, by keeping an accurate track of the movement. The robotics entail developing personalized devices for assisting and assessing several sensorimotor functions. Rehabilitation using robotics is considered to be effective in therapy for individuals with motor impairments caused by stroke. The thriving wearables and robotics have resulted in many companies prioritizing the manufacture of wearables and robotics. Such aspects are expected to stimulate market growth. The restraining factors of market growth evaluated are the lack of skilled specialists and stringent regulations.
REGIONAL INSIGHTS
The geographical segregation of the global neurorehabilitation device market includes the evaluation of Europe, North America, Asia Pacific, and the rest of the world. North garnered the largest revenue share in the global market, as of 2019. The factors attributed to the contribution aspects of the market are the increasing aging population and the growing funding by the federal governments in the region.
COMPETITIVE INSIGHTS
With the presence of key players in the market, the competitive rivalry is projected to be high during the forecast period. Also, there is a rising focus on new product developments. Some of the leading players in the market are Abbott Laboratories, Bionik Laboratories Corp, Biometrics Ltd, Ectron Limited, Bioxtreme, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Global Neurorehabilitation Device Market Forecast 2019-2028
Table of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Growing Elderly Populace
3.2.2. Growing Neurorehabilitation Device Wearables And Robotics
3.2.3. Significant Rise In Neurological Diseases
3.2.4. Technological Advancements In The Neurorehabilitation Device
3.3. Key Restraints
3.3.1. Dearth Of Skilled Specialists In The Neurorehabilitation Device Market
3.3.2. High Cost Of Treatment
3.3.3. Stringent Regulations
4. Key Analyticals
4.1. Porter's Five Forces Analysis
4.1.1. Threat Of New Entrants
4.1.2. Threat Of Substitutes
4.1.3. Bargaining Power Of Buyer
4.1.4. Bargaining Power Of Supplier
4.1.5. Intensity Of Competitive Rivalry
4.2. Supply Chain Analysis
4.3. Timeline Of Neurorehabilitation Device
4.4. Key Buying Criteria
4.5. Opportunity Matrix
4.6. Vendor Landscape
4.7. Key Investment Insights
5. Market By Product
5.1. Neuro-Robotic System
5.2. Brain Computer Interface
5.3. Wearable Device
5.4. Non-Invasive Stimulator
5.5. Other Products
6. Market By Application
6.1. Stroke
6.2. Cerebral Palsy
6.3. Parkinson's Disease
6.4. Multiple Sclerosis
6.5. Other Applications
7. Market By End-User
7.1. Hospital/Clinic
7.2. Research Institute
7.3. Cognitive Care Center
7.4. Other End-User
8. Geographical Analysis
8.1. North America
8.1.1. The United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. The United Kingdom
8.2.4. Italy
8.2.5. Russia
8.2.6. Belgium
8.2.7. Poland
8.2.8. Rest Of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. Australia & New Zealand
8.3.4. India
8.3.5. South Korea
8.3.6. Thailand
8.3.7. Indonesia
8.3.8. Vietnam
8.3.9. Rest Of Apac
8.4. Rest Of World
8.4.1. Latin America
8.4.2. Middle East & Africa
9. Company Profiles
9.1. Abbott Laboratories
9.2. Biometrics Ltd
9.3. Bionik Laboratories Corp
9.4. Bioxtreme
9.5. Ectron Limited
9.6. Ekso Bionics Holdings Inc
9.7. Helius Medical Technologies
9.8. Hokoma Ag
9.9. Kinestica
9.10. Kinova
9.11. Medtronic Inc
9.12. Neurostyle Pte Ltd
9.13. Tyromotion Gmbh
List of Tables
Table 1: Market Snapshot - Neurorehabilitation Device
Table 2: Global Neurorehabilitation Device Market, By Product, Historical Years, 2016-2019 ($ Million)
Table 3: Global Neurorehabilitation Device Market, By Product, Forecast Years, 2019-2028 ($ Million)
Table 4: Global Neuro-Robotic System Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 5: Global Neuro-Robotic System Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 6: Global Brain Computer Interface Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 7: Global Brain Computer Interface Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 8: Global Wearable Device Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 9: Global Wearable Device Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 10: Global Non-Invasive Stimulator Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 11: Global Non-Invasive Stimulator Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 12: Global Other Products Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 13: Global Other Products Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 14: Global Neurorehabilitation Device Market, By Application, Historical Years, 2016-2019 ($ Million)
Table 15: Global Neurorehabilitation Device Market, By Application, Forecast Years, 2019-2028 ($ Million)
Table 16: Global Stroke Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 17: Global Stroke Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 18: Global Cerebral Palsy Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 19: Global Cerebral Palsy Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 20: Global Parkinson's Disease Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 21: Global Parkinson's Disease Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 22: Global Multiple Sclerosis Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 23: Global Multiple Sclerosis Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 24: Global Other Applications Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 25: Global Other Applications Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 26: Global Neurorehabilitation Device Market, By End-User, Historical Years, 2016-2019 ($ Million)
Table 27: Global Neurorehabilitation Device Market, By End-User, Forecast Years, 2019-2028 ($ Million)
Table 28: Global Hospitals/Clinic Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 29: Global Hospitals/Clinic Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 30: Global Research Institute Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 31: Global Research Institute Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 32: Global Cognitive Care Center Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 33: Global Cognitive Care Center Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 34: Global Other End-Users Market, By Region, Historical Years, 2016-2019 ($ Million)
Table 35: Global Other End-Users Market, By Region, Forecast Years, 2019-2028 ($ Million)
Table 36: Global Neurorehabilitation Device Market, By Geography, 2019-2028 ($ Million)
Table 37: North America Neurorehabilitation Device Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 38: North America Neurorehabilitation Device Market, By Country, Forecast Years, 2019-2028 (In $ Million)
Table 39: Europe Neurorehabilitation Device Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 40: Europe Neurorehabilitation Device Market, By Country, Forecast Years, 2019-2028 (In $ Million)
Table 41: Asia Pacific Neurorehabilitation Device Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 42: Asia Pacific Neurorehabilitation Device Market, By Country, Forecast Years, 2019-2028 (In $ Million)
Table 43: Rest Of World Neurorehabilitation Device Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 44: Rest Of World Neurorehabilitation Device Market, By Region, Forecast Years, 2019-2028 (In $ Million)
List of Figures
Figure 1: Number Of Elderly Populace, By Geography, (In Million)
Figure 2: Increase In The Prevalence Of Parkinson's Disease Globally (Million)
Figure 3: Porter's Five Force Analysis
Figure 4: Timeline Of Neurorehabilitation Device Market
Figure 5: Opportunity Matrix
Figure 6: Vendor Landscape
Figure 7: Key Investment Insights
Figure 8: Global Neurorehabilitation Device Market, By Product, In 2019
Figure 9: Global Neurorehabilitation Device Market, By Neuro-Robotic System, 2019-2028 ($ Million)
Figure 10: Global Neurorehabilitation Device Market, By Brain Computer Interface, 2019-2028 ($ Million)
Figure 11: Global Neurorehabilitation Device Market, By Wearable Device, 2019-2028 ($ Million)
Figure 12: Global Neurorehabilitation Device Market, By Non-Invasive Stimulator, 2019-2028 ($ Million)
Figure 13: Global Neurorehabilitation Device Market By, Other Products, 2019-2028 ($ Million)
Figure 14: Global Neurorehabilitation Device Market, By Application, In 2019
Figure 15: Global Neurorehabilitation Device Market, By Stroke, 2019-2028 ($ Million)
Figure 16: Global Neurorehabilitation Device Market, By Cerebral Palsy, 2019-2028 ($ Million)
Figure 17: Global Neurorehabilitation Device Market, By Parkinson's Disease, 2019-2028 ($ Million)
Figure 18: Global Neurorehabilitation Device Market, By Multiple Sclerosis, 2019-2028 ($ Million)
Figure 19: Global Neurorehabilitation Device Market, By Other Applications, 2019-2028 ($ Million)
Figure 20: Global Neurorehabilitation Device Market, By End-User, In 2019
Figure 21: Global Neurorehabilitation Device Market, By Hospital/Clinic, 2019-2028 ($ Million)
Figure 22: Global Neurorehabilitation Device Market, By Research Institute, 2019-2028 ($ Million)
Figure 23: Global Neurorehabilitation Device Market, By Cognitive Care Center, 2019-2028 ($ Million)
Figure 24: Global Neurorehabilitation Device Market, By Other End-User, 2019-2028 ($ Million)
Figure 25: North America Neurorehabilitation Device Market, Country Outlook, 2019 & 2028 (In %)
Figure 26: The United States Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 27: Canada Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 28: Europe Neurorehabilitation Device Market, Country Outlook, 2019 & 2028 (In %)
Figure 29: Germany Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 30: France Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 31: The United Kingdom Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 32: Italy Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 33: Russia Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 34: Belgium Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 35: Poland Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 36: Rest Of Europe Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 37: Asia Pacific Neurorehabilitation Device Market, Country Outlook, 2019 & 2028 (In %)
Figure 38: China Neuro Rehabilitation Device Market, 2019-2028 ($ Million)
Figure 39: Japan Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 40: Australia & New Zealand Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 41: India Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 42: South Korea Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 43: Thailand Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 44: Indonesia Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 45: Vietnam Neurorehabilitation Device Market, 2019-2028 (In $ Million)
Figure 46: Rest Of Asia Pacific Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 47: Rest Of World Neurorehabilitation Device Market, Regional Outlook, 2019 & 2028 (In %)
Figure 48: Latin America Neurorehabilitation Device Market, 2019-2028 ($ Million)
Figure 49: Middle East & Africa Neurorehabilitation Device Market, 2019-2028 ($ Million)
Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 112
According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......
Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 110
Report Overview:
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......
Global Epilepsy Therapeutics Market Research Report 2023
Published: 14-Dec-2023 Price: US 2900 Onwards Pages: 86
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Laboratories
- Cephalon
- Novartis
- Pfizer
- Johnson & Johnson
- GlaxoSmithKline
- Sanofi
- Sunovion Pharmaceuticals......
Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 109
Market Overview of Global Autism Spectrum Disorder market:
According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
Global Autism Spectrum Disorder Market Status and Outlook 2023-2028
Published: 24-Nov-2023 Price: US 3160 Onwards Pages: 109
Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......
Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 112
Market Overview of Global Epilepsy Therapeutics market:
According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years.
Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......
Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Oct-2023 Price: US 3380 Onwards Pages: 98
Market Overview of Global Gabapentin market:
According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......
2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel
Published: 09-Oct-2023 Price: US 2500 Onwards Pages: 89
This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Aut......
Global Gabapentin Market Insights, Forecast to 2029
Published: 27-Sep-2023 Price: US 4900 Onwards Pages: 112
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
